Edenbridge Pharmaceuticals

3 articles about Edenbridge Pharmaceuticals

• Edenbridge Pharmaceuticals Names Douglas S. Boothe as CEO

  12/20/2023

  Edenbridge Pharmaceuticals, the U.S. subsidiary of Dexcel Pharma, announced that Douglas S. Boothe has been named Chief Executive Officer, effective January 1, 2024.

• Edenbridge Pharmaceuticals Announces the Launch of DARTISLA ODT

  2/28/2022

  Edenbridge Pharmaceuticals, LLC (“Edenbridge”) today announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub for DARTISLA ODT, as well as in retail pharmacies throughout the country.

• Edenbridge Pharmaceuticals Announces U.S. FDA Approval of DARTISLA ODT (Glycopyrrolate) Orally Disintegrating Tablets

  12/17/2021

  Edenbridge’s first 505(b)(2) branded drug to be granted FDA approval.